Sigyn Therapeutics, Inc. – OTC:SIGY

Sigyn Therapeutics stock price today

$2.65
-0.5
-15.87%
Financial Health
0
1
2
3
4
5
6
7
8
9

Sigyn Therapeutics stock price monthly change

-40.00%
month

Sigyn Therapeutics stock price quarterly change

-40.00%
quarter

Sigyn Therapeutics stock price yearly change

+2563.85%
year

Sigyn Therapeutics key metrics

Market Cap
 5.41M
Enterprise value
 6.68M
P/E
 -1.84
EV/Sales
 N/A
EV/EBITDA
 -1.99
Price/Sales
 N/A
Price/Book
 -2.52
PEG ratio
 -0.02
EPS
 -1.59
Revenue
 N/A
EBITDA
 -2.55M
Income
 -3.56M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Sigyn Therapeutics stock price history

Sigyn Therapeutics stock forecast

Sigyn Therapeutics financial statements

Profit Margin

Sigyn Therapeutics, Inc. (OTC:SIGY): Profit margin
Jun 2023 0 -723.12K
Sep 2023 0 -905.72K
Dec 2023 14.49K -1.17M -8115.17%
Mar 2024 0 -758.08K
SIGY income statement history

Debt to Assets

Sigyn Therapeutics, Inc. (OTC:SIGY): Debt to assets
Jun 2023 361817 3.40M 940.82%
Sep 2023 387223 3.96M 1023.41%
Dec 2023 321806 3.73M 1160.42%
Mar 2024 323295 4.34M 1343.83%
SIGY balance sheet history

Cash Flow

Sigyn Therapeutics, Inc. (OTC:SIGY): Cash Flow
Jun 2023 -328.69K 0 30K
Sep 2023 -364.04K 0 405K
Dec 2023 -127.89K 0 75K
Mar 2024 -235.61K 0 256.76K
SIGY cash flow history

Sigyn Therapeutics alternative data

Sigyn Therapeutics
Employees

Sigyn Therapeutics, Inc. (OTC:SIGY): Employee count
Aug 2023 4
Sep 2023 4
Oct 2023 4
Nov 2023 4
Dec 2023 4
Jan 2024 4
Feb 2024 4
Mar 2024 4
Apr 2024 4
May 2024 4
Jun 2024 5
Jul 2024 5

Sigyn Therapeutics other data

Sigyn Therapeutics
Hedge Funds Holdings Q1 2023

0.06% -0.00%
of SIGY is owned by hedge funds
1 +0
hedge funds hold SIGY stock
21K +0
shares is hold by hedge funds
SIGY hedge funds holdings changes

Frequently Asked Questions (FAQ)

  • What's the price of Sigyn Therapeutics stock today?

    One share of Sigyn Therapeutics stock can currently be purchased for approximately $2.65.

  • When is Sigyn Therapeutics's next earnings date?

    Unfortunately, Sigyn Therapeutics's (SIGY) next earnings date is currently unknown.

  • Does Sigyn Therapeutics pay dividends?

    No, Sigyn Therapeutics does not pay dividends.

  • How much money does Sigyn Therapeutics make?

    Sigyn Therapeutics has a market capitalization of 5.41M.

  • What is Sigyn Therapeutics's stock symbol?

    Sigyn Therapeutics, Inc. is traded on the OTC under the ticker symbol "SIGY".

  • What is Sigyn Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Sigyn Therapeutics?

    Shares of Sigyn Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Sigyn Therapeutics have?

    As Jul 2024, Sigyn Therapeutics employs 5 workers, which is 25% more then previous quarter.

  • When Sigyn Therapeutics went public?

    Sigyn Therapeutics, Inc. is publicly traded company for more then 4 years since IPO on 8 Jan 2021.

  • What is Sigyn Therapeutics's official website?

    The official website for Sigyn Therapeutics is sigyntherapeutics.com.

  • Where are Sigyn Therapeutics's headquarters?

    Sigyn Therapeutics is headquartered at 8880 Rio San Diego Drive, San Diego, CA.

  • How can i contact Sigyn Therapeutics?

    Sigyn Therapeutics's mailing address is 8880 Rio San Diego Drive, San Diego, CA and company can be reached via phone at +61 93682000.

Sigyn Therapeutics company profile:

Sigyn Therapeutics, Inc.

sigyntherapeutics.com
Exchange:

OTC

Full time employees:

5

Industry:

Biotechnology

Sector:

Healthcare

Sigyn Therapeutics, Inc. operates as a development-stage therapeutic technology company. It offers Sigyn Therapy, a blood purification technology to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths. The company also engages in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; CytoVesicles; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. The company is headquartered in San Diego, California.

+61 93682000
8880 Rio San Diego Drive
San Diego, CA 92106

CIK: 0001642159
:
: